Prot #ITL-2001-CL-301: MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

Project: Research project

Project Details

StatusActive
Effective start/end date4/16/244/16/27

Funding

  • Medpace Clinical Research LLC (Prot #ITL-2001-CL-301 // Prot #ITL-2001-CL-301)
  • Intellia Therapeutics, Inc. (Prot #ITL-2001-CL-301 // Prot #ITL-2001-CL-301)